Posted by ABMN Staff on May 4th, 2024
Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report) Director Nassim Usman sold 20,000 shares of the stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $14.13, for a total value of $282,600.00....
More of this article »